logo

Cancer Genetics Inc. (CGIX)



Trade CGIX now with
  Date
  Headline
5/15/2018 7:07:52 AM Cancer Genetics Q1 Net Loss $4.5 Mln Or $0.16/Shr Vs Loss $9.6 Mln Or $0.51/Shr Last Year
4/27/2018 8:34:27 AM Cancer Genetics Completes Sale Of BioServe Biotechnologies (India) Private Limited To REPROCELL
4/2/2018 4:07:31 PM Cancer Genetics FY17 Loss/share $1.01 Vs. Loss $1.00 Year Ago
3/14/2018 10:33:18 AM PierianDx Partners With Cancer Genetics To Provide Comprehensive Precision Oncology Testing And Workflow Solution
2/5/2018 8:12:56 AM Cancer Genetics: Panna Sharma To Be Stepping Down As President, CEO And A Director
12/19/2017 7:33:36 AM Cancer Genetics Gets New York State Approval For FDA-Approved Oncomine Dx Target Test By Thermo Fisher Scientific
12/11/2017 7:34:10 AM Cancer Genetics Advances Understanding Of Immune Response In Lymphomas By Combining PD-L1 Analysis With RNA Analysis
12/8/2017 9:00:28 AM Cancer Genetics Prices Registered Direct Offering Of 3.50 Mln Units At $2.00/unit
11/9/2017 7:29:14 AM Cancer Genetics Q3 Total Revenues $8.0 Mln, Up 19%
6/27/2017 7:45:11 AM Cancer Genetics Unveils Thermo Fisher Scientific's Oncomine Dx Target
4/3/2017 7:05:44 AM Cancer Genetics Announce Strategic Partnership With Mendel Health Focused On Using Mendel.ai Deep-learning Engine
3/23/2017 7:38:38 AM Cancer Genetics 2016 Revenues Up 50% Year-over-year To $27 Mln
1/9/2017 9:28:37 AM Cancer Genetics. Announces Multiple Agreements & Collaborations To Develop Liquid Biopsy Programs
12/5/2016 8:16:10 AM Cancer Genetics Listed By Merck As A National Reference Laboratory For KEYTRUDA Companion Diagnostic Testing